TIA news stories

New melanoma trial in Perth supported by TIA facility

Read More »

March 11, 2024 No Comments

New company established to operate NSW’s world-leading viral vector facility

Read More »

February 26, 2024 No Comments

TIA and Phenomics Australia partnership reinforces commitment to bridge the translational gap

Read More »

December 13, 2023 No Comments

Compounds Australia enters a new era of compound storage, access, and supply

Read More »

December 8, 2023 No Comments

TIA funding allows QEDDI to open to external drug discoveries

Read More »

November 1, 2023 No Comments

TIA-supported facility helps kick-start an Australian-developed cancer drug that has now been approved by the US FDA

Read More »

October 17, 2023 No Comments

TIA support bringing a koala vaccine a step closer

Read More »

July 12, 2023 No Comments

New partnership supports advances in therapeutic development research

Read More »

July 4, 2023 No Comments

MRFF backs new national venture to strengthen homegrown medicine outcomes

Read More »

June 26, 2023 No Comments

How TIA is helping infectious disease researchers build translational skills

Read More »

June 23, 2023 No Comments

New biotech company receives funding to halt the progression of kidney disease

Read More »

June 6, 2023 No Comments

Technical feasibility advice part of expanded TIA support schemes

Read More »

February 20, 2023 No Comments

Demand booms for experimental mRNA from UQ BASE

Read More »

January 19, 2023 No Comments

Clamp2 provides vaccine hope for future pandemics

Read More »

December 6, 2022 No Comments

Medical chemist brings commercialisation experience to ATMCF role

Read More »

December 1, 2022 No Comments

When food kills

Read More »

November 28, 2022 No Comments

Research Infrastructure Specialist Position Paper

Read More »

November 24, 2022 No Comments

How TIA is helping to accelerate the development of Australian COVID-19 treatments

Read More »

November 22, 2022 No Comments

TIA supports bid to overcome leading cause of hospital ICU deaths

Read More »

November 17, 2022 No Comments

Developing a pain medication that doesn’t cause addiction

Read More »

November 14, 2022 No Comments

Virus and superbug vaccines at the core of TIA-supported research

Read More »

October 31, 2022 No Comments

Prescient Therapeutics Limited building LEGO-like solutions to address rapidly mutating cancers

Read More »

October 24, 2022 No Comments

Cancer medicine research advances with TIA expertise

Read More »

September 20, 2022 No Comments

National research infrastructure working together to improve the health of Australians

Read More »

September 7, 2022 No Comments

TIA partners with AAMRNet to accelerate therapeutic development research

Read More »

July 25, 2022 No Comments

NCRIS: The power behind Australia’s science

Read More »

February 19, 2022 No Comments

🏏 TIA reaches a century of voucher awards! 🏏

Read More »

December 14, 2021 No Comments

New role looks at worm saliva to eradicate diabetes

Read More »

October 18, 2021 No Comments

New Zealand accessing Australian expertise to build mRNA COVID-19 vaccines

Read More »

September 16, 2021 No Comments

Pipeline Navigator 2021-22 (Round 1) is now open for applications

Read More »

August 31, 2021 No Comments